SANTHERA
Live / Applied — Fourth extension granted (statement of use) (as of 03 Sept 2025)
What this means for you
Not registered yet, but its 19 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97638731
- Mark type
- Design + words
- Filed
- 19 Oct 2022
- Published for opposition
- 04 Jul 2023
- Attorney of record
- Patrick J. Concannon
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of ocular, inflammatory and pulmonary diseases, but not in the field of oncology and rheumatoid arthritis
Owner
- Santhera Pharmaceuticals (Schweiz) AG, Pratteln, CH
- Santhera Pharmaceuticals (Schweiz) AG, Pratteln, CH
Prior registrations
Prosecution history
- 27 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2025 — SOU EXTENSION 4 GRANTED
- 29 Aug 2025 — SOU EXTENSION 4 FILED
- 29 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Aug 2025 — SOU EXTENSION 3 GRANTED
- 28 Feb 2025 — SOU EXTENSION 3 FILED
- 28 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Aug 2024 — SOU EXTENSION 2 GRANTED
- 28 Aug 2024 — SOU EXTENSION 2 FILED
- 28 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Feb 2024 — CORRECTED NOA E-MAILED